Viewing Study NCT04954794


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-27 @ 4:38 AM
Study NCT ID: NCT04954794
Status: COMPLETED
Last Update Posted: 2024-10-31
First Post: 2021-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02)
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module